JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹19 Cr | ₹16 Cr | ₹16 Cr | ₹21 Cr | ₹18 Cr |
What is the latest Total Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹18 Cr |
How is Total Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 14.90 | |
| Mar2024 | ₹16 Cr | 3.91 | |
| Mar2023 | ₹16 Cr | -25.93 | |
| Mar2022 | ₹21 Cr | 18.27 | |
| Mar2021 | ₹18 Cr | - | |
Compare Total Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹544.4 Cr | 0.7% | 23.2% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,566.0 Cr | 1.2% | 5.3% | 0.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,594.0 Cr | -0.7% | -2.1% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,826.0 Cr | -3.2% | 4.1% | 20.2% | Stock Analytics | |
| CIPLA | ₹123,504.0 Cr | -0.2% | -6.7% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,132.0 Cr | 0.2% | -2.7% | 2% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 0.7% |
23.2% |
3.3% |
| SENSEX | 1.4% |
2% |
10.2% |
You may also like the below Video Courses